Two rotenoids isolated from BoerhaaVia diffusa (Nyctaginaceae), boeravinones G (1) and H (2), have been found to potently inhibit the drug efflux activity of breast cancer resistance protein (BCRP/ABCG2), a multidrug transporter responsible for cancer cell resistance to chemotherapy. The isolation of nine additional rotenoid derivatives (3-11), including the new boeravinones I (10) and J (11), from the extract of B. diffusa roots allowed us to establish structure-activity relationships toward inhibition of BCRP-mediated drug transport activity. The results show the positive roles of a methoxy group at position 6 of ring B and the absence of a substituent at position 10, and the requirement for a 6a/12a double bond between rings B and C. In contrast, both contraction of ring B, to give a coumaronochromone (11), and tetrasubstitution of ring D appeared to be detrimental for the inhibitory potency. The present study provides the first data on the BCRP-inhibiting activity of rotenoid derivatives, indicating boeravinones as a new class of interesting BCRP inhibitors.

Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors / AHMED BELKACEM, A; Macalou, S; Borrelli, Francesca; Capasso, Raffaele; Fattorusso, Ernesto; TAGLIALATELA SCAFATI, Orazio; DI PIETRO, A.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 50:(2007), pp. 1933-1938. [10.1021/jm061450q]

Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors

BORRELLI, FRANCESCA;CAPASSO, RAFFAELE;FATTORUSSO, ERNESTO;TAGLIALATELA SCAFATI, ORAZIO;
2007

Abstract

Two rotenoids isolated from BoerhaaVia diffusa (Nyctaginaceae), boeravinones G (1) and H (2), have been found to potently inhibit the drug efflux activity of breast cancer resistance protein (BCRP/ABCG2), a multidrug transporter responsible for cancer cell resistance to chemotherapy. The isolation of nine additional rotenoid derivatives (3-11), including the new boeravinones I (10) and J (11), from the extract of B. diffusa roots allowed us to establish structure-activity relationships toward inhibition of BCRP-mediated drug transport activity. The results show the positive roles of a methoxy group at position 6 of ring B and the absence of a substituent at position 10, and the requirement for a 6a/12a double bond between rings B and C. In contrast, both contraction of ring B, to give a coumaronochromone (11), and tetrasubstitution of ring D appeared to be detrimental for the inhibitory potency. The present study provides the first data on the BCRP-inhibiting activity of rotenoid derivatives, indicating boeravinones as a new class of interesting BCRP inhibitors.
2007
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors / AHMED BELKACEM, A; Macalou, S; Borrelli, Francesca; Capasso, Raffaele; Fattorusso, Ernesto; TAGLIALATELA SCAFATI, Orazio; DI PIETRO, A.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 50:(2007), pp. 1933-1938. [10.1021/jm061450q]
File in questo prodotto:
File Dimensione Formato  
Manuscript.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 92.78 kB
Formato Adobe PDF
92.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/200732
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 89
  • ???jsp.display-item.citation.isi??? 78
social impact